Rep. Gilbert Ray Cisneros, Jr. Acquires Shares of Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM)Defense World · Oct 14, 2026
AtriCure to Announce Third Quarter 2026 Financial ResultsBusiness Wire · Oct 13, 2026
AtriCure (NASDAQ:ATRC) Reaches New 12-Month High – Here’s What HappenedDefense World · Sep 25, 2026
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research · Sep 14, 2026
AtriCure CTO Sells 3,657 SharesThe Motley Fool · Sep 12, 2026
Do Options Traders Know Something About AtriCure Stock We Don't?Zacks Investment Research · Sep 10, 2026AtriCure, Inc. creates, produces, and markets medical devices for the surgical treatment of cardiac tissue and intercostal nerves. Its market reach spans the United States, Europe, Asia, and other international territories. The company's product line features various ablation technologies.
| Date | Est. | Actual | |
|---|---|---|---|
| Jul 23, 2026 | -$0.00 | $0.18 | Beat |
| May 5, 2026 | -$0.07 | $0.00 | Beat |
| Feb 17, 2026 | -$0.04 | $0.06 | Beat |
| Oct 29, 2025 | -$0.11 | -$0.01 | Beat |
| Jul 29, 2025 | -$0.15 | -$0.13 | Beat |
| Apr 29, 2025 | -$0.25 | -$0.14 | Beat |